RET kinase inhibitors (KinaRx)

N/A

Report date: 2025/06/11 10:43:30
NME

Base Information

Drug NameRET kinase inhibitors (KinaRx)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase receptor RET inhibitorsAnticancer protein kinase inhibitors
TargetsTyrosine-protein kinase receptor RET
Therapy Area/IndicationsLung NeoplasmsThyroid NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKinaRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesKinaRx Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsThyroid NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A